201 related articles for article (PubMed ID: 25023248)
21. Hospital case volume and appropriate prescriptions at hospital discharge after acute myocardial infarction: a nationwide assessment.
Schiele F; Capuano F; Loirat P; Desplanques-Leperre A; Derumeaux G; Thebaut JF; Gardel C; Grenier C
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):50-7. PubMed ID: 23233747
[TBL] [Abstract][Full Text] [Related]
22. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
Winkelmayer WC; Charytan DM; Levin R; Avorn J
Am J Kidney Dis; 2006 Feb; 47(2):301-8. PubMed ID: 16431259
[TBL] [Abstract][Full Text] [Related]
23. Impact of medication therapy discontinuation on mortality after myocardial infarction.
Ho PM; Spertus JA; Masoudi FA; Reid KJ; Peterson ED; Magid DJ; Krumholz HM; Rumsfeld JS
Arch Intern Med; 2006 Sep; 166(17):1842-7. PubMed ID: 17000940
[TBL] [Abstract][Full Text] [Related]
24. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
26. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
27. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors.
Zhang Y; Baik SH; Chang CC; Kaplan CM; Lave JR
Am Heart J; 2012 Sep; 164(3):425-433.e4. PubMed ID: 22980311
[TBL] [Abstract][Full Text] [Related]
28. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):895-900. PubMed ID: 18936454
[TBL] [Abstract][Full Text] [Related]
29. Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
[TBL] [Abstract][Full Text] [Related]
30. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
31. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
Naderi SH; Bestwick JP; Wald DS
Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
[TBL] [Abstract][Full Text] [Related]
32. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
[TBL] [Abstract][Full Text] [Related]
33. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?
Moran A; Goldman L
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697
[TBL] [Abstract][Full Text] [Related]
34. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
[TBL] [Abstract][Full Text] [Related]
35. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
36. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
37. Statin use and risk of epilepsy: a nested case-control study.
Etminan M; Samii A; Brophy JM
Neurology; 2010 Oct; 75(17):1496-500. PubMed ID: 20975051
[TBL] [Abstract][Full Text] [Related]
38. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004.
Margulis AV; Choudhry NK; Dormuth CR; Schneeweiss S
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1088-97. PubMed ID: 21538672
[TBL] [Abstract][Full Text] [Related]
39. Statin use associated with a reduced risk of pneumonia requiring hospitalization in patients with myocardial infarction: a nested case-control study.
Lin CF; Chang YH; Liu JC; Chuang MT; Chien LN
BMC Cardiovasc Disord; 2016 Jan; 16():24. PubMed ID: 26823081
[TBL] [Abstract][Full Text] [Related]
40. Relation between combining evidence-based medications on mortality following myocardial infarction in patients with and without renal impairment.
Tay EL; Chan M; Tan V; Sim LL; Tan HC; Lim YT; Ho KT; Chia BL; Wong PS; Yeo TC
Acta Cardiol; 2010 Apr; 65(2):211-6. PubMed ID: 20458829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
